"Designing Growth Strategies is in our DNA"

U.S. Intraocular Lens (IOL) Market Size, Share & COVID-19 Impact Analysis, By Type (Monofocal and Premium {Multifocal, Toric, and Others}), By Material (Polymethylmethacrylate (PMMA) and Foldable {Hydrophobic Acrylic, Hydrophobic Acrylic, and Silicone & Collamer}), By End-user (Hospitals & Ambulatory Surgery Centers, Specialty Clinics, and Academic & Research Institutes) and Forecast, 2023-2030

Published On : May 16, 2023 | Format: PDF | Report ID: FBI107513

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. Intraocular Lens (IOL) market size was valued at USD 1.44 billion in 2022. The market is projected to grow from USD 1.53 billion in 2023 to USD 2.40 billion by 2030, exhibiting a CAGR of 6.6% during the forecast period.


Generally, cataracts occur due to old age or chronic disorders such as high blood pressure, diabetes, and obesity. The growing number of cataract and glaucoma cases has surged the demand for ophthalmic procedures such as cataract surgery. Most cataract procedures require intraocular lenses, which contributes chiefly to the market growth. Furthermore, numerous advanced studies are being conducted to evaluate and deliver these novel technologies for improved patient outcomes. Such factors are predicted to contribute significantly to the U.S. IOL market growth.


Also, rising government programs and the active participation of key players to contribute to the reduction of cataract surgery burden have augmented market expansion.



  • For instance, in June 2022, Bausch & Lomb Incorporated raised awareness by introducing a media campaign for cataracts and the importance of routine screening for this treatable condition in the U.S.  The campaign was organized throughout the month of June during Cataract Awareness Month. Bausch + Lomb published educational resources and content on social media platforms under the hashtag #CataractsDontWait. This initiative was done with an aim to increase awareness about this condition and to develop innovative initiatives to control and treat blindness.


COVID-19 IMPACT


Decline in Adoption of Ophthalmic Care Due to COVID-19 Negatively Impacted the Market Growth


There are multiple factors that negatively impacted the U.S. market during the COVID-19 pandemic. Overall, the pandemic had a negative impact on the market. Due to the lockdown procedures, there were interruptions in conducting consultations and surgical procedures for ophthalmic care. This situation contributed to the drop in the number of patient visits and surgeries for cataracts, during the pandemic.


Moreover, the key market players witnessed a considerable revenue decline due to the lack of demand for IOLs during the COVID-19 restrictions.



  • For instance, the major global players, such as Alcon, Inc. and Johnson & Johnson Vision Care, Inc., recorded significant declines of -2.6% and -29.8%, respectively, in 2020 for the U.S. annual sales. In 2021, the company experienced a surge in its annual revenues.


Furthermore, increasing patient visits and surgeries for ophthalmic care are anticipated to increase the adoption of these devices, leading to a steady growth during 2023-2030.


LATEST TRENDS


Request a Free sample to learn more about this report.


Advanced Product Launches to Cater to Patient Needs to Propel Market Growth


In recent years, the U.S. IOL market witnessed a trend of advanced product launches such as extended depth of focus. The conventional IOLs do not provide a sufficient degree of accommodation. Compared with monofocal Intraocular Lens, Extended Depth of Focus (EDOF) IOL product provides more elongated focus and range. Therefore, it is expected that such advanced IOLs adopted more by patients with refractive error.



  • For instance, in January 2021, Alcon Inc. launched the AcrySof IQ Vivity IOL (Vivity) in the U.S. This new presbyopia correcting Intraocular Lens (IOL) is the first and only ono-diffractive EDOF IOLs in the U.S.


Currently, more companies are becoming engaged in gaining regulatory approvals and launching new products for extended depth of focus products. Such a scenario contributes to the market growth during the forecast period significantly.


DRIVING FACTORS


Rising Prevalence of Cataracts to Boost the Number of Procedures in the Market


One of the foremost drivers that positively impacts the market growth is the increasing prevalence of cataract surgeries in the U.S. The factors that have contributed to the rise in the number of cataract cases include diabetes, obesity, high blood pressure, and smoking. The growing prevalence of cataracts has led to a strong demand for these ophthalmic procedures.



  • According to an article published by Healio Ophthalmology in 2021, approximately 4.0 million cataract procedures are performed annually in the U.S. Such trends are expected to lead to market growth in the forecast period.


Furthermore, the geriatric population is more prone to cataract incidence. After the age of 40, the proteins in the lens of the eye start breaking down and clump together. This clump makes a cloudy area on the lens and this causes cataracts. Thus, the aging population in the U.S. is the major factor driving the number of cataract procedures.


Robust Government Initiatives to Eliminate Cataracts to Surge the Demand for IOLs


The emphasis of the government and other healthcare agencies on the promotion of cataract awareness has led to a strong demand for IOLs in the market. This is owing to the rising economic burden of cataract surgeries in hospitals and other healthcare facilities. In the U.S., various government and non-government bodies are working to increase public awareness regarding cataracts as well as contributing to control and treat blindness. Along with educating patients, they also carry out campaigns that provide suitable surgery options with innovative product offerings. This has led to a significant number of patients opting for these ophthalmic surgeries in the U.S.



  • For instance, the American Society of Cataract and Refractive Surgery (ASCRS) launched the U.S. based charitable cataract surgery program in 2014. Under this Operation Sight charitable program, more than 7,500 surgeries were delivered through a nationwide network of volunteer surgeons.


Such programs for serving the financially vulnerable and uninsured people who cannot afford or access care are driving the intraocular lens market size in the U.S.


RESTRAINING FACTORS


High Costs Associated with Cataract Surgeries to Hinder Market Growth


Even though the demand for these surgical procedures is constantly growing, some factors limit the market growth in the U.S. The burden and costs associated with cataract surgeries restrain the market growth. The main barrier to using general eye care services is the indirect costs associated with cataract surgeries. The main factors that affect the average cost of cataract surgery include an IOL, type of surgery, surgeon's fees, surgery setting, and pre-and post-operative care.



  • For instance, according to an article published by GoodRx, Inc. in 2022, cataract surgery costs from USD 1,600.0 to USD 2,600.0 under Medicare claims in the U.S.

  • Similarly, as per a published article by Vision Centre in 2023, cataract surgery can cost up to USD 3,500 to USD 7,000 per eye without insurance in the U.S.


Thus, a significant economic burden contributes to the decline in the volume of cataract procedures. Therefore, such factors hamper the adoption of IOLs in the U.S.


SEGMENTATION


By Type Analysis


To know how our report can help streamline your business, Speak to Analyst


Rising Cataract Surgeries Enabled the Monofocal Segment to Attain the Highest Share


Based on type, the market is categorized into monofocal and premium. The premium segment is further sub-segmented into multifocal, toric, and others. The monofocal segment captured the largest U.S. Intraocular Lens (IOL) market share in 2022. The dominance of the segment is due to increasing number of cataract surgeries and the high prevalence of chronic diseases in the U.S. population. Also, monofocal lenses are cost-effective compared to premium, contributing to segmental growth.


The premium segment which includes the toric IOL is anticipated to witness the fastest growth over the forecast period. The segment’s growth can be attributed to the rising adoption of premium offerings and the implementation of various strategic initiatives by players operating to capture the untapped avenues of the market.



  • Additionally, according to an article published by Healio Ophthalmology in 2021, the growth of advanced technology/premium IOLs in the U.S. was approximately 16.0% in 2020 and may grow to 20.0% in 2021.


By Material Analysis


Robust Benefits of Foldable IOLs Aided to Hold Major Market Share in 2022 


The market is classified into polymethylmethacrylate (PMMA) and foldable based on material. The foldable segment is sub-segmented into hydrophobic acrylic, hydrophilic acrylic, and silicone & collamer.


The foldable segment captured the maximum market share in 2022. A strong cataract prevalence rate and many product launches for hydrophobic acrylic material IOLs contribute to segmental growth. For instance, in March 2022, Alcon, Inc. launched the Clareon family of IOLs in the U.S. with other next-generation, reusable Clareon Monarch IV Delivery Systems. This system provides precise and controlled implantation designed specifically from the new Clareon material.


The second most dominant segment is the polymethylmethacrylate (PMMA) segment. The PMMA segment exhibited a lower share due to limited usage in recent times. It is also being replaced by newer advanced materials such as hydrophobic acrylic, silicone, and hydrophilic acrylic materials available in the market.


By End-user Analysis


Significant Number of Specialty Clinics offering Services to Exhibit Highest CAGR during 2023-2030


Based on end-user, the market is classified into hospitals & ambulatory surgery centers, specialty clinics, and academic & research institutes.


The hospitals & ambulatory surgery centers segment captured the highest market share in 2022. The increasing number of patients with ophthalmic conditions such as cataracts and glaucoma require IOLs and surgeries that are carried out extensively in hospitals. Such a factor has primarily driven segmental growth.


The specialty clinics segment held the second most dominant position. Easy accessibility to cataract services due to the large number of optometrists’ offices in the U.S. contributes to the expansion of the eye clinics segment. According to the U.S. Bureau of Labor Statistics 2021, there are a total 6,900 optometrist offices in the U.S.


The academic & research institutes are anticipated to witness steady growth throughout the forecast period.


KEY INDUSTRY PLAYERS


Alcon and J&J Leads the Market in 2022 Owing to Strong Product Portfolio and Market Presence


The competitive landscape of the U.S. market is consolidated in terms of nature, as key companies such as Alcon Inc., Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, and HOYA Corporation accounted for a significant proportion of the market share in 2022. Alcon Inc. is one of the leading players in the market. The company's prominent position in the market is due to its strong focus on mergers & acquisitions, new product launches, and collaborations to expand its portfolio.



  • For instance, in March 2022, Alcon Inc. launched the Clareon family of IOLs in the U.S. using the most advanced material. Moreover, the company’s wide network across the U.S. to offer its product offering also contributes to the company's strong market share.


Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.) held a considerable market share in 2022. The introduction of an extended depth of focus IOL to increase the brand presence of the company and a strong emphasis on partnerships and acquisitions with other major players to widen the portfolio are some factors that have strengthened the company’s market presence.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • September 2022: Johnson & Johnson Vision Care, Inc. introduced TECNIS Symfony OptiBlue in the U.S. and some countries of the EMEA region.

  • April 2022: Johnson & Johnson Vision Care, Inc. presented data on improved surgical outcomes of its cataract and refractive portfolio at the American Society of Cataract and Refractive Surgery (ASCRS) (2022) Annual Meeting in Washington, D.C.

  • June 2021: Johnson & Johnson Vision Care, Inc. introduced TECNIS Synergy and TECNIS Synergy Toric II intraocular lens in the U.S. and Canada for cataract patients.

  • May 2021: Johnson & Johnson Vision Care, Inc. received approval from the U.S. FDA for TECNIS Synergy and TECNIS Synergy Toric II IOLs, and the Health Canada approval for TECNIS Synergy Toric II IOLs

  • March 2021: Rayner Group received the U.S. FDA approval for RayOne EMV, a new non-diffractive IOL solution.


REPORT COVERAGE


To gain extensive insights into the market, Request for Customization


The research report provides a deep analysis of the market overview. The U.S. market is segmented by type, material, and end-user. The report offers insights into market dynamics, prevalence of cataracts, number of cataract surgeries, new product launches, key industry developments, an overview of government cataract initiatives, and an overview of regulatory and reimbursement scenarios. The report also provides a competitive analysis and COVID-19's impact on the market.


Report Scope & Segmentation






















































  ATTRIBUTE



  DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 6.6% from 2023 to 2030



Unit



Value (USD billion)



Segmentation



By Type, Material, End-user, and Region



By Type




  • Monofocal

  • Premium

    • Multifocal 

    • Toric 

    • Others





By Material




  • Polymethylmethacrylate (PMMA)

  • Foldable

    • Hydrophobic Acrylic

    • Hydrophilic Acrylic

    • Silicone & Collamer





By End-user




  • Hospitals & Ambulatory Surgery Centers

  • Specialty Clinics

  • Academic & Research Institutes






Frequently Asked Questions

Fortune Business Insights says that the market stood at USD 1.44 billion in 2022 and is projected to reach USD 2.40 billion by 2030.

The U.S. market is projected to grow at a CAGR of 6.6% from 2023 to 2030.

By type, the monofocal segment will lead the market.

The rising number of cataract procedures due to strong government initiatives is one of the most prominent driving factors in the market.

Alcon, Inc., Bausch & Lomb Incorporated, and Carl Zeiss Meditec AG are the major players in the market.

The surge in demand for ophthalmic care and robust novel product launches are some of the factors expected to drive the adoption of these devices.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 80

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X